Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Operating expenses
Research and development	$ 128,698	$ 108,671	$ 290,895	$ 486,759
Selling, general and administrative	887,241	1,081,189	1,762,375	2,449,745
Total operating expenses	1,015,939	1,189,860	2,053,270	2,936,504
Loss from operations	(1,015,939)	(1,189,860)	(2,053,270)	(2,936,504)
Interest expense	(7,413)	(2,106)	(9,878)	(4,490)
Impairment loss on investment				(300,000)
Net loss	(1,023,352)	(1,191,966)	(2,063,148)	(3,240,994)
Deemed dividend on preferred stock	782,879	627,705	782,879	627,705
Net loss applicable to common stockholders	$ (1,806,231)	$ (1,819,671)	$ (2,846,027)	$ (3,868,699)
Net loss per share – Basic and diluted
Net loss per share – Basic and diluted	$ (0.14)	$ (0.14)	$ (0.21)	$ (0.30)
Weighted average common shares outstanding	13,312,777	12,902,549	13,232,422	12,818,232